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Abstract. The sensation of a lump in the throat (SLT) is not a 
rarely encountered symptom. The etiology of SLT appears to be 
multifactorial, and the psychological characteristics, stress and 
pressure of a psychiatric disorder may be significant factors in 
SLT. Hangekobokuto, one of the traditional herbal medicines, 
is a known drug that has an effect on SLT. The efficacy of a 
short-term hangekobokuto treatment on SLT was evaluated. 
To assess whether a 2-week prescription of hangekobokuto 
improves SLT mainly in patients with respiratory diseases, 
a retrospective study was performed between April 2013 and 
August 2015. During the study period, a total of 43 patients were 
treated with hangekobokuto. Twelve (27.9%) of the 43 patients 
were reported to experience completely effective treatment (SLT 
completely disappeared), and 14 (32.6%) experienced moder-
ately effective treatment (25-99% SLT disappeared). Patients 
with bronchial asthma and those without a medical history of 
respiratory disease exhibited a good response to hangekobokuto. 
No specific predictive factor of the response to hangekobokuto 
on SLT was identified in the multivariate regression analysis. 
Therefore, the present results suggested that hangekobokuto 
could be one of the treatment choices for uncontrolled SLT.
Introduction
The sensation of a lump in the throat (SLT), also known as 
globus hystericus, is not a rarely encountered symptom. It has 
been reported in 7-14% of the population worldwide (1-4). The 
etiology of SLT appears to be multifactorial, and the psycho-
logical characteristics, stress and pressure of a psychiatric 
disorder may be significant factors in SLT (5). In addition, 
certain studies suggested that bronchial asthma (6), and 
gastroesophageal reflux disease (GERD) may be major factors 
of SLT (7,8). Hangekobokuto (Tsumura Co., Tokyo, Japan), one 
of the traditional herbal medicines that has been developed 
by Zhang Zhongjing, a well‑known physician of traditional 
Chinese medicine in the third century, is known as an effec-
tive drug on SLT in North-East Asia (9). Treating SLT by 
hangekobokuto has been previous studied, for example in Jin 
Gui Yao Lue (a classic clinical book of essential prescriptions 
of traditional Chinese medicine written by Zhang Zhongjing 
in the third century). A number of Kampo doctors are expe-
rienced in this regard, and the effects of hangekobokuto on 
SLT have been reported by certain Japanese otolaryngologists, 
as published in Japanese (10-12). However, to the best of our 
knowledge, there have been no studies published in English. 
English publications are required to introduce the usefulness 
of this traditional herbal medicine to numerous ‘non-Kampo 
doctors’ in areas other than North-East Asia.
SLT appears to not be a serious symptom, but it is diffi-
cult to completely treat in patients with respiratory diseases, 
particularly in those with bronchial asthma who have even 
undergone treatment with inhaled corticosteroid/long 
acting β2-agonist (ICS/LABA) or oral corticosteroids. As 
aforementioned, treating SLT by hangekobokuto is not a new 
area of research; however, whether the effect could be achieved 
in the short-term has not been established. The present study 
evaluated the effect of a short-term, 2-week prescription of 
hangekobokuto on SLT in patients with respiratory diseases.
Patients and methods
Patients. The retrospective study was performed at Mito 
Medical Center, University of Tsukuba, Mito Kyodo General 
Hospital (Mito, Japan), by evaluating medical charts of 
patients with respiratory diseases between April 2013 and 
August 2015. All the consecutive patients with SLT as their 
primary complaint who underwent a 2-week prescription of 
hangekobokuto were evaluated in this study. All were outpa-
tient clinic patients, and none were admitted. Patients with 
laryngeal, pharyngeal diseases and connective tissue diseases 
were excluded, but those with SLT with a medical history of 
GERD were included in this study.
Prescription of hangekobokuto. The indication and contra-
indication of hangekobokuto was explained and the study 
obtained an agreement for administering hangekobokuto for 
SLT, and prescribed the drug (2.5 g three times a day) for 
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2 weeks. Other drugs, which were already prescribed, were 
continued with hangekobokuto.
Evaluation of the effect of hangekobokuto. After a 2-week admin-
istration of hangekobokuto, changes in SLT were evaluated. The 
verbal rating scale was used to determine the change of SLT: 
Completely effective (CE), SLT had completely disappeared; 
moderately effective (ME), 25-99% of SLT had disappeared; not 
effective (NE), 0-24% of SLT had disappeared; and worsened 
symptom (WS), SLT was worse than prior to the prescription.
Ethics. The study was conducted in accordance with the 
Declaration of Helsinki Good Clinical Practice and was 
approved by the Institutional Review Board at Mito Medical 
Center, University of Tsukuba for human studies (no. 15-13).
Statistical analysis. Comparisons between two groups were 
evaluated using χ2 test and multiple logistic regression analysis. 
P<0.05 was considered to indicate a statistically significant 
difference.
Results
Patient characteristics. During the study period, a total of 
43 patients were treated with hangekobokuto. The patient 
characteristics are summarized in Table I. The median age of 
the patients was 72 years (range, 17-90 years). Nine (26.5%) 
of the patients were male. A total of 29 patients (67.4%) had 
bronchial asthma. All had initiated ICS/LABA therapy.
Change of SLT following hangekobokuto therapy. Table II shows 
the response to hangekobokuto. Twelve (27.9%) of the 43 patients 
had CE, and 14 (32.6%) exhibited ME. However, 17 (39.5%) had 
NE, but none exhibited WS. In particular, 20 (69.0%) of the 
29 patients with bronchial asthma and 4 (57.1%) of the 7 patients 
with no medical history of respiratory diseases were effective, 
and tended to exhibit a higher response (CE and ME) rate than 
that in 7 patients with other respiratory diseases than bronchial 
asthma (28.6%), but the difference was not statistically signifi-
cant (P=0.1149 and P=0.8679, respectively).
Predictive factors of the response to hangekobokuto on 
SLT. Table III shows the results of the prediction of the SLT 
response to hangekobokuto using multiple logistic regression 
Table I. Characteristics of the 39 patients treated with hangeko-
bokuto.
Characteristics Patients
Median age, years (range) 72 (17-90)
Gender, no.
  Male 9
  Female 34
Medical history of respiratory disease, no.
  None 7
  Bronchial asthma 29
  Other respiratory diseases  7
  Chronic obstructive pulmonary disease 2
  Idiopathic pulmonary fibrosis 2
  Bronchiectasis 2
  Lung cancer 1
Table II. Patient responses to hangekobokuto.
Response Patients, no. (%)
Overall 43
  Completely effective 12 (27.9)
  Moderately effective 14 (32.6)
  No change 17 (39.5)
  Worsened symptom 0 (0.0)
Patients with BA 29
  Completely effective 8 (27.6)
  Moderately effective 12 (41.4)
  No change 9 (31.0)
  Worsened symptom 0 (0.0)
Patients with respiratory   7
diseases other than BA
  Completely effective 0 (0.0)
  Moderately effective 2 (28.6)
  No change 5 (71.4)
  Worsened symptom 0 (0.0)
Patients with no history   7
of respiratory disease
  Completely effective 4 (57.1)
  Moderately effective 0 (0.0)
  No change 3 (42.9)
  Worsened symptom 0 (0.0)
BA, bronchial asthma; ICS/LABA, inhaled corticosteroid/long 
acting β2-agonist.
Table III. Predictive factors of the response to hangekobokuto 
on the sensation of a lump of the throat using multiple regres-
sion analysis.
Factors Hazard ratio 95% CI P‑value
Age 1.916 0.449-8.176 0.3800
Gender 1.079 0.176‑6.625 0.9348
History of 1.677 0.066-42.539 0.7539
respiratory disease
Drug prescription
  ICS/LABA 0.333 0.018-6.045 0.4570
  Antitussive drug 0.510 0.104-2.505 0.4071
  Expectorant 1.344 0.264-6.836 0.7214
  PPI and H2 1.326 0.202-8.719 0.7692
ICS/LABA, inhaled corticosteroid/long acting β2-agonist; PPI, 
proton pump inhibitor; H2, H2 antagonist; CI, confidence interval.
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analysis. Female, elderly (>65 years) patients with a medical 
history of respiratory disease, and simultaneous prescription 
of other drugs including ICS/BALA were not evaluated as 
predictive factors of the response to hangekobokuto on SLT.
Adverse events of hangekobokuto therapy. There was no 
severe (grade 3-4, common toxicity criteria) event in the 
hangekobokuto therapy. Only 1 patient experienced tentative 
nausea (grade 1), but this disappeared quickly following the 
termination of the hangekobokuto treatment.
Discussion
SLT is a nonspecific symptom of throat discomfort. The etiology 
of SLT appears to be multifactorial, and the psychological char-
acteristics, stress and pressure of a psychiatric disorder may be 
significant factors in SLT (5). Bronchial asthma may also be a 
major factor of SLT (6). In the present study, three points were 
focused on as follows; however, a strong conclusion could not 
be derived. First, 20 of the 29 patients with bronchial asthma, 
who were treated with inhaled ICS/LABA, reported CE and 
ME. These results suggested that prescription of hangekobo-
kuto could be considered for the bronchial asthma patients 
with SLT. However, the effectiveness of hangekobokuto in 
patients who were prescribed ICS/LABA simultaneously to 
hangekobokuto could not be estimated due to the small number 
of patients, although ICS/LABA was not a predictive factor of 
the response to hangekobokuto on SLT in the multiple regres-
sion analysis (Table III). Second, certain previous studies have 
suggested that GERD may be a major factor of SLT (7,8). By 
contrast, other studies did not support GERD as an etiology of 
SLT (9). In the present study, there was efficacy of hangekobo-
kuto in 4 of the 7 patients who had been prescribed a proton 
pump inhibitor or H2 antagonist. Third, the majority of patients 
were female and they exhibit a higher response compared to 
male patients. However, there was no statistical difference in 
the response between them. Larger prospective studies are 
required to confirm these results and explain their mechanisms.
Hangekobokuto (Banxia-Houpo-Tang) is a traditional 
herbal medicine (formula of magnolia and pinelliae), which 
has been administered to patients with airway obstructions 
(by Zhang Zhongjing, a well‑known physician of traditional 
Chinese medicine in the third century). Hangekobokuto 
modulates cerebral levels of 5-hydroxytryptamine, noradrena-
line, dopamine and substance-P (9,11). Improvement of the 
swallowing function may be associated with their increased 
cerebral levels (9,11). Hangekobokuto is well-known in 
North-East Asia for its effective treatment of psychological 
characteristics, stress and pressure of psychiatric disorder 
as well as bronchial asthma and impairment of swallowing 
reflex (9,12). Our previous study reported the successful 
treatment of an elderly patient with bronchial asthma (6). 
The patient complained of SLT, which was not controlled 
by ICS/LABA and oral prednisolone, and was treated by the 
addition of a 2-week hangekobokuto treatment to these drugs. 
In the present study, a retrospective study was performed and 
showed the effect of hangekobokuto on SLT in patients with 
respiratory diseases, including those with bronchial asthma.
In Kampo traditional herbal medicine, ‘Sho’ is the impor-
tant concept (13,14). The physical and psychological conditions 
of the patients are evaluated as having ‘Jitsu-sho’ and ‘Kyo-sho’. 
Hangekobokuto has been evaluated as more effective in 
patients with ‘Kyo-sho’, low body mass index and a depressive 
mood disorder (13,14). In the present study, however, it did not 
appear that the efficacy of hangekobokuto was obtained in such 
patients. This may be due to the small sample size of the study.
There were several limitations of the present study. First, 
it was a small-sized retrospective study. Second, it was not a 
placebo-controlled study. Third, the study included patients 
with or without bronchial asthma and GERD, and several 
drugs for these diseases. Despite these limitations, the results 
provide important information regarding the treatment of SLT.
The etiology of SLT is likely multifocal. In a patient with 
SLT, several factors may be associated with SLT. Bronchial 
asthma and GERD may be two of the etiology associated with 
SLT. Therefore, therapy for such diseases must be indicated 
at first; however, if SLT is uncontrolled by such therapies, 
prescription of hangekobokuto may be considered.
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